-transparent.png){kind=logo}
During the period November 1976 to September 1980, 2703 babies born in one Edinburgh hospital were screened in the neonatal period by estimation of their serum creatine kinase levels for Duchenne muscular dystrophy. Among the 2336 male babies tested, none proved to be affected and only 16 required second specimens to be obtained. Overall the false positive rate in the study was 0.78%. This study confirms that neonatal screening for Duchenne muscular dystrophy is feasible in a British hospital setting and is here most conveniently carried out on the 5th day of life along with routine testing for phenylketonuria.
Related Publications
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
November 1978,
Lancet (London, England),
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
April 1979,
La Nouvelle presse medicale,
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
January 1990,
Nursing standard (Royal College of Nursing (Great Britain) : 1987),
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
May 1984,
Revue medicale de Liege,
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
March 1989,
Lancet (London, England),
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
June 1979,
Developmental medicine and child neurology,
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
April 1990,
BMJ (Clinical research ed.),
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
April 1980,
Developmental medicine and child neurology,
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
July 1989,
Archives of disease in childhood,
R Skinner, and
A E Emery, and
G Scheuerbrandt, and
J Syme
April 1976,
Archives of disease in childhood,
